89bio to Present at Upcoming Investor Conferences

Rhea-AI Summary

89bio, a clinical-stage biopharmaceutical company listed on Nasdaq under the symbol ETNB, announced a corporate update and participation in investor meetings at two major healthcare conferences. The BofA Securities 2021 Health Care Conference is scheduled for May 13, 2021, at 1:15 PM ET, followed by the RBC Capital Markets 2021 Global Healthcare Conference on May 19, 2021, at 9:45 AM ET. Interested parties can access a live and archived webcast of the presentations on the company's website.

SAN FRANCISCO, May 05, 2021 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases, today announced that Company’s Management will provide a corporate update and participate in one-on-one investor meetings at the BofA Securities 2021 Health Care Conference on Thursday, May 13, 2021 at 1:15 PM ET and the RBC Capital Markets 2021 Global Healthcare Conference on Wednesday, May 19, 2021 at 9:45 AM ET.

The live and archived webcast of the presentation will be accessible in the investor section of 89bio’s website.

About 89bio
89bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. The company’s lead product candidate, BIO89-100, is a specifically engineered glycoPEGylated analog of FGF21. BIO89-100 is being developed for the treatment of nonalcoholic steatohepatitis (NASH) and severe hypertriglyceridemia (SHTG). 89bio is headquartered in San Francisco with operations in Herzliya, Israel.

Investor Contact:
Ryan Martins
Chief Financial Officer
investors@89bio.com 

Media Contact:
Peter Duckler
773-343-3069
pduckler@w2ogroup.com 

FAQ

What is 89bio's stock symbol on Nasdaq?

89bio is listed on Nasdaq under the stock symbol ETNB.

When will 89bio present at the BofA Securities 2021 Health Care Conference?

89bio will present at the BofA Securities 2021 Health Care Conference on May 13, 2021, at 1:15 PM ET.

When is the RBC Capital Markets 2021 Global Healthcare Conference where 89bio will participate?

The RBC Capital Markets 2021 Global Healthcare Conference is on May 19, 2021, at 9:45 AM ET.

Where can I find the webcast for 89bio's presentations?

The webcast for 89bio's presentations can be found in the investor section of the company's website.

What is the focus of 89bio's research and development?

89bio focuses on developing therapies for liver and cardio-metabolic diseases, including its lead product candidate BIO89-100.